HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

M2/M4 muscarinic receptor binding in the anterior cingulate cortex in schizophrenia and mood disorders.

Abstract
We have previously shown a decrease in [(3)H]pirenzepine binding to M1/M4 muscarinic receptors in the anterior cingulate cortex in schizophrenia but not in major depression or bipolar disorder. The present study aimed to extend these findings by examining the binding of [(3)H]AF-DX 384 to M2/M4 receptors in the same cohort of subjects. Using quantitative autoradiography we measured [(3)H]AF-DX 384 binding in the anterior cingulate cortex of 15 schizophrenia, 15 bipolar, 15 major depression and 15 control cases. Post-mortem tissue was obtained from the Stanley Foundation Brain Bank. [(3)H]AF-DX 384 binding had a homogenous distribution amongst the layers of the anterior cingulate cortex, was higher in males than in females and declined with prolonged storage of tissue. An inverse correlation between [(3)H]AF-DX384 binding and age of onset of the disease was observed in the schizophrenia group suggesting that the earlier the age at onset the higher the binding was. In the depression group, there was a significant effect of gender on [(3)H]AF-DX 384 binding with females having lower binding in comparison to males. In the bipolar group, there was a significant inverse correlation between antipsychotic medication and [(3)H]AF-DX 384 binding, suggesting that the higher the dose of medication the lower the binding was. No differences in [(3)H]AF-DX 384 binding were seen between the four groups. The present results provide no evidence of M2/M4 receptor alterations in the anterior cingulate cortex in schizophrenia and affective disorders and extend the body of evidence implicating cortical M1 but not M2 involvement in the pathology and pharmacotherapy of schizophrenia.
AuthorsKaterina Zavitsanou, Andrew Katsifis, Yinghua Yu, Xu Feng Huang
JournalBrain research bulletin (Brain Res Bull) Vol. 65 Issue 5 Pg. 397-403 (May 15 2005) ISSN: 0361-9230 [Print] United States
PMID15833594 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Parasympatholytics
  • Receptor, Muscarinic M2
  • Receptor, Muscarinic M4
  • Tritium
  • AFDX 384
  • Pirenzepine
Topics
  • Adult
  • Age of Onset
  • Analysis of Variance
  • Autoradiography
  • Brain Mapping
  • Case-Control Studies
  • Dose-Response Relationship, Drug
  • Female
  • Gyrus Cinguli (drug effects, metabolism)
  • Humans
  • Male
  • Middle Aged
  • Mood Disorders (metabolism)
  • Organ Size
  • Parasympatholytics (pharmacology)
  • Pirenzepine (analogs & derivatives, pharmacology)
  • Postmortem Changes
  • Protein Binding (drug effects)
  • Receptor, Muscarinic M2 (metabolism)
  • Receptor, Muscarinic M4 (metabolism)
  • Regression Analysis
  • Schizophrenia (metabolism)
  • Sex Factors
  • Tritium (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: